aod9604 clinical trial doses AOD-9604 Dosage Guide: Complete Protocol for Safe Administration SLU-PP-332 Dosing Protocols and Expectations

In 2000, a research study was carried out in obese Zucker rats where the AOD 9604 peptide was given daily for 19 consecutive days

Evaluation of: Glycerol production (a marker of lipolysis) 2-deoxyglucose uptake (a marker of insulin signaling) DNA synthesis (a marker of proliferation) What they found: AOD-9604 stimulated lipolysis dose-dependently from 10 M, with a plateau at 10 M Full hGH stimulated lipolysis to a similar maximum, but with different kinetics AOD-9604 did not affect glucose uptake or DNA synthesis at all, whereas hGH inhibited both (the classic lipotoxic GH effect) Fragments with different sequence (from the N-terminal part of hGH) had no lipolytic effect Why it matters: This was the first publication of AOD-9604

doi:10.3390/ijms22158199

These effects are believed to result from enhanced fatty acid oxidation and improved cellular energy balance, contributing to overall metabolic health optimization